About the role
Remote (UK-based) Executive Director role leading clinical pharmacology and pharmacometrics strategy across Recursion's rare disease and oncology drug development programs. Responsibilities include developing pharmacology strategy to support the overall product development plan, running modeling and simulation (PK, PK-PD, and safety analyses) to inform decision-making, providing pharmacology input on Phase 1-3 clinical study designs, and authoring regulatory submission sections (Investigator's Brochures, INDs, NDAs) while collaborating with clinical, translational, and preclinical teams.
Requires a PhD in Pharmaceutical Sciences/Pharmacokinetics, an MD with clinical pharmacology expertise, or a PharmD with a clinical pharmacology fellowship, plus 10+ years of biotech/pharmaceutical drug development experience and proficiency with modeling software (WinNonlin, Monolix, NONMEM, R). Oncology experience is preferred but not required. Salary range: £136,500 - £167,200 annually, plus bonus and equity.
Text as published by the employer. Always confirm details on the employer's site.